Neurotherapeutics Course
  • Home
  • About This Training Program
  • Submit an Application
  • Faculty
  • 2025 Course Materials
  • Important Information
  • 2025 Course Schedule
  • Course Evaluation
  • 2023 Course Lecture Videos
  • Additional Videos

Course Lecture Videos
​
2023 Course Offering of Training in Neurotherapeutics Discovery and Development for Academic Scientists


Overview

Session 1: Target and Pathway Interrogation
James Inglese, PhD, National Center for Advancing Translational Sciences, NIH

Session 2: Moving from Hit to Lead to Clinical Candidate
James Barrow, Ph.D., Johns Hopkins School of Medicine

Session 3: ADME
​Kennan Marsh, Ph.D., AbbVie

Session 4: Antibody-Based Therapies
Gai Ayalon, PhD

Session 6: Antisense Oligonucleotides (ASOs)
Gene Liau, Ph.D.

​Session 7: Animal Models
Greg Carr, PhD, Johns Hopkins University

Session 8: Formulation and Routes of Administration
Maureen Donovan, Ph.D., University of Iowa

Session 9: Alternative Routes of Administration
James Cloyd, III, Pharm.D., University of Minnesota

Session 10: Toxicology
Adaline Smith, PhD, DABT

Session 11: IND Enabling Studies and Preparation of the IND
Ted Spack, Ph.D., AxoSim, Inc.

Session 12: Academic Drug Discovery Vignette
Barbara Slusher, Ph.D., MAS, Johns Hopkins Drug Discovery

Session 13:  Rigor in Translational Drug Discovery and Development
Shai Silberberg, Ph.D., NIH/NINDS

​Session 14: Intellectual Property
Jeffrey Childers, J.D., Ph.D., Casimir Jones

Session 15: Clinical Considerations in the Non-Clinical Phase of Drug Discovery and Development
James J. Vornov, M.D., Ph.D., Johns Hopkins School of Medicine and Medpace

​Session 16: Funding Academic Drug Discovery Research
Charles L. Cywin, PhD, NIH/NINDS

Special Evening Guest Lecture

Adrian R. Krainer, Ph.D.
Cold Spring Harbor Laboratory

Lecture Videos from 2018 Course Offering
Collaborator’s Logos